Yesterday, plenty of companies announced their financial results for the third fiscal quarter that had ended back on September 30, 2021 and one of those was US Nuclear Corp (OTCMKTS:UCLE).
On Monday, UCLE stock ended lower by 6.32% to $0.3750 with more than 18k shares, compared to its average volume of 42K shares. The stock has moved within a range of $0.3610 – 0.4195 after opening trade at $0.42.
The company, which is involved in manufacturing advanced biological, radiation and chemical detection instrumentation, saw its stock decline by as much as 6% yesterday after the announcement of its financial results. In light of the decline, it might be a good time for investors to perhaps figure out if the decline in the US Nuclear Corp could in fact be an opportunity or not.
Hence, it could be a good idea to take a look at some of the highlights from the financial results. The company managed to generate sales of as much as $683,771 for the quarter and that reflected significant growth from the prior year period, when it managed to bring in sales of only $484,318. US Nuclear Corp noted that as the company continues to recover from the effects of the coronavirus pandemic, its sales has continued to recover.
In addition to that, the expenses related to sales, general and administrative costs declined to $747290 as compared to $1021507 in the prior year period.
UCLE stock is trading below the 50-Day and 200-Day Moving averages of $0.43 and $0.58. Moreover, the stock is trading below the 20-Day moving average of $0.39. The stock is down 11% over the past month.